New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.98+0.16 (+0.58%)
At close: 04:00PM EDT
27.98 0.00 (0.00%)
After hours: 05:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,354,554
2,354,554
2,237,215
2,289,463
2,122,353
Operating expenses
Research development
52,000
52,000
177,106
200,084
26,289
Selling general and administrative
249,748
249,748
227,303
182,826
181,715
Total operating expenses
862,404
862,404
1,314,323
858,748
461,901
Operating income or loss
1,492,150
1,492,150
922,892
1,430,715
1,660,452
Interest expense
187,187
187,187
187,961
166,142
157,059
Total other income/expenses net
322,834
322,834
-583,202
-76,907
170,182
Income before tax
1,700,088
1,700,088
230,064
1,241,201
1,701,954
Income tax expense
0
0
0
0
0
Income from continuing operations
1,700,088
1,700,088
230,064
1,241,201
1,701,954
Net income
1,134,834
1,134,834
42,832
619,728
975,040
Net income available to common shareholders
1,527,560
1,527,560
42,832
619,728
495,198
Basic EPS
0.39
2.54
0.10
1.49
2.51
Diluted EPS
0.39
2.53
0.10
1.49
2.51
Basic average shares
446,678
447,601
437,963
414,794
388,135
Diluted average shares
446,678
602,900
437,972
414,802
388,135